Clinical trial
Bipolar Study in Adults at Least 18 Years of Age
NCT00067938 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00067938 |
|---|---|
| Title | Bipolar Study in Adults at Least 18 Years of Age |
| Official title | Lamictal for Use in Treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | lamotrigine |
| Enrollment | 1,200 |
| Start date | Aug 1, 2003 |
| Primary completion | Aug 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Sep 5, 2003 |
| Last update posted | Sep 1, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: